Bästa Lung Cancer podcaster (2024)

1
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01

5d ago

—

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Docetaxel alone or in combination with ramucirumab is the current standard of care for the second-line treatment of non-small cell lung cancer (NSCLC), but there are several limitations of docetaxel-containing regimens. That’s why there’s interest in identifying new therapies like datopotamab deruxteca…

1
Ep 90. 2024 Reflections on Lung Cancer 30:10

10d ago30:10

30:10

In our final episode of the year, Dr. Paul Wheatley-Price sits down with none other than the President of Lung Cancer Canada, Dr. Stephanie Snow, to reflect on all the progress we've made in the lung cancer community this year. From new treatments, diagnostic tools and screening updates, all the way to everything LCC has been up to this year, and o…

1
Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer 48:03

15d ago48:03

48:03

Dr Edward B Garon shares his perspectives on the evolving therapeutic landscape for patients with lung cancer.Av Neil Love, MD

1
Cancer in the Workplace, Health Insurance, Finances and Returning to School 1:06:03

15d ago1:06:03

1:06:03

- Overview of the Challenges Young Adults Living with Cancer Face- Talking with the Health Care Team About Survivorship Questions & Concerns- Choosing Who & What to Tell Others: Disclosure- School: Deciding How to Deal with Financing Education– Community College, Technical Training, College, Graduate School – Scholarships- Financial Concerns, Inclu…

1
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial

5d ago

—

Host: Jacob Sands, MD Guest: Alex Spira, MD, PhD, FACP Valemetostat is a novel therapy that’s demonstrated clinical efficacy and safety across multiple hematologic malignancies, but what role might it have in treating patients with advanced, unresectable, or metastatic non-squamous non-small cell lung cancer (NSCLC)? To find out, an upcoming trial …

1
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results

5d ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Thomas Egenod, MD In an effort to identify additional treatment options for resectable non-small cell lung cancer (NSCLC), the NeoCOAST-2 study is evaluating the efficacy and safety of combining durvalumab, chemotherapy, and novel agents in the neoadjuvant setting as well as combining durvalumab with …

1
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases

5d ago

—

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Unfortunately, brain metastases are very common in patients with non-small cell lung cancer (NSCLC). That’s why the phase 3 TROPION-Lung01 trial examined the efficacy and safety of datopotamab deruxtecan (Dato-DXd) for advanced non-squamous NSCLC with brain metastases. Joining Dr. Jacob Sands to share …

1
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker

15d ago

—

Host: Jacob Sands, MD Guest: Marina Garassino, MD Datopotamab deruxtecan (Dato-DXd) is a second-line antibody drug conjugate that could lead to improved progression-free survival in patients with advanced or metastatic non-small cell lung cancer. Given these potential benefits, it’s important to identify biomarkers that may predict a patient’s resp…

1
Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer 58:47

17d ago58:47

58:47

Dr Heather Wakelee from Stanford University School of Medicine in California discusses the implications of recent datasets for the current and future use of nontargeted therapy for metastatic non-small cell lung cancer.Av Neil Love, MD

1
Non-Small Cell Lung Cancer: Biomarker Testing and Treatment Trends 58:50

18d ago58:50

58:50

- Non-Small Cell Lung Cancer Overview in the Context of COVID, Seasonal Flu & RSV- Definition of Genomics & Biomarker Testing- The Difference Between Genomics & Genetics- The Role of Biomarker Testing in the Treatment of Non-Small Cell Lung Cancer- Specific Examples of How Biomarker Testing May Inform Treatment Decisions- Precision Medicine & Non-S…

1
Challenges Young Adults with Cancer Face: Coping Tips 1:10:55

22d ago1:10:55

1:10:55

- Overview of Young Adults Living with Cancer, Including Delays in Diagnosis- Where to Seek Cancer Treatment: Selecting Your Oncology Health Care Team, Including Young Adult Cancer Programs- The Importance of Treatment Summaries- Follow Up with Your Oncologist & Primary Care Doctor- Managing Post Treatment Side Effects/Late Effects- Talking with th…

1
Non-Small Cell Lung Cancer: What’s New 55:44

25d ago55:44

55:44

- Non-Small Cell Lung Cancer Treatment- Current Standard of Care- The Role of Chemotherapy, Radiation Oncology, and Targeted Cancer Therapies- New Treatment Approaches- The Role of Biomarkers and Precision Medicine in Informing Treatment Choices- How Clinical Trials Contribute to Treatment Options- New Ways to Manage Treatment Side Effects, Symptom…

1
Ep 89. A Journey From Weather to Warrior: Kim MacDonald 24:45

1M ago24:45

24:45

In this episode, Dr. Paul Wheatley-Price chats with a familiar face for many Canadians - Kim MacDonald, a TV Broadcaster on The Weather Network for over 25 years. In December 2016, Kim was diagnosed with stage 2B breast cancer and underwent numerous treatments including a double mastectomy. She talks about her experience living with cancer, her dec…

1
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences 1:00:11

1M ago1:00:11

1:00:11

Dr Suresh S Ramalingam from the Emory University School of Medicine in Atlanta, Georgia and Dr Gregory J Riely from Memorial Sloan Kettering Cancer Center in New York, New York discuss the implications of recent data sets for the current and future management of lung cancer.Av Neil Love, MD

1
Ep 88. Témoignage d’une patiente : Julie Desjardins 25:29

1M ago25:29

25:29

La Dre Nathalie Daaboul s’entretient avec Julie Desjardins de la vallée d'Annapolis, en Nouvelle-Écosse, dans notre premier épisode du balado en français Voix du cancer du poumon. Julie lutte contre un cancer du poumon ALK+ de stade IV depuis qu’elle a reçu un diagnostic inattendu en juillet 2022, alors qu’elle n’avait que 39 ans. Elle fait part de…

1
Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects 1:04:47

1M ago1:04:47

1:04:47

- Why Chemotherapy Causes Treatment Side Effects & Discomfort- Working with Your Healthcare Team to Better Understand & Cope with Potential Treatment Side Effects with a Plan to Manage or Prevent Them- Common Treatment Gastrointestinal (GI) Side Effects - You May Not Experience All of These - Loss of Appetite, Nausea, Vomiting, Mouth Sores, Stomati…

1
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Lung Cancer 1:05:42

1M ago1:05:42

1:05:42

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer.Av Neil Love, MD

1
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from Recent Major Conferences 54:39

2M ago54:39

54:39

Dr Stephen V Liu from Georgetown University Hospital in Washington, DC, reviews recently presented data with and newly approved therapies for localized and advanced lung cancers.Av Neil Love, MD

1
Ep 87. Self-Advocacy Without Anger: Sonia’s Lung Cancer Story 35:12

2M ago35:12

35:12

In this episode, Dr. Paul Wheatley-Price chats with Sonia Turingia who was diagnosed with Stage 4 lung cancer in Spring 2023. Sonia shares her journey being diagnosed with cancer, navigating the challenges during treatment, why she believes it's important to self-advocate, and how to do that without anger.…

1
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review 42:46

2M ago42:46

42:46

Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigational therapies in small cell lung cancer from the 2024 World Conference on Lung Cancer.Av Neil Love, MD

1
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer 1:00:07

2M ago1:00:07

1:00:07

Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid share their perspectives on recent datasets from the 2024 World Conference on Lung Cancer on the management of non-small cell lung cancer without actionable genomic alterations.…

1
Ep 86. Best of 2024 WCLC & ESMO 37:44

2M ago37:44

37:44

In this episode, Dr. Paul Wheatley-Price chats with Dr. Peter Ellis, Thoracic Medical Oncologist at the Juravinski Cancer Center and Professor at McMaster University about the highlights at this year's annual World Conference of Lung Cancer (WCLC) in San Diego and European Society of Medical Oncology (ESMO) Conference in Barcelona. Some very exciti…

1
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR 58:13

3M ago58:13

58:13

Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.…

1
Ep 80. Research in Canada: Equity in Clinical Trials 30:31

3M ago30:31

30:31

In this episode, Dr. Paul Wheatley-Price sits down with guests Dr. Lacey Pitre, Medical Oncolgist & Dr. Stacey Santi, Medical Research Chair at Health Sciences North in Sudbury, Ontario. Drs. Pitre and Santi are one of the recipients of a $100,000 research grant offered jointly by Pfizer Canada, Lung Cancer Canada, Lung Health Foundation, and Assoc…

1
Ep 84. All About Common Sense Oncology 33:09

3M ago33:09

33:09

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Christopher Booth, Medical Oncologist and Health Services Researcher at Queen’s University, to talk about Common Sense Oncology. CSO is an initiative Started by Dr. Booth amongst Canadian and global partners to ensure that patients have access to cancer treatments that provide meaningful i…

1
Ep 83. The History Of Lung Cancer in Canada 30:19

3M ago30:19

30:19

In this episode, Dr. Paul Wheatley-Price chats with Dr. Stephanie Mercier, Medical Oncology Resident at the University of Ottawa & Dr. Stephen Lam, Respirologist and Lead of the BC Screening Program at the University of British Columbia. They talk about the recent paper they published together highlighting the significant Canadian contributions to …

1
Ep 82. The Role of Nursing in Cancer Care 23:18

3M ago23:18

23:18

In this episode, Dr. Paul Wheatley-Price sits down with Shannon Farley, a Nurse Practitioner (NP) at the William Osler Health System in Brampton, ON. They chat about what an NP is and the difference with other types of nurses, current challenges in the ERs and how nurses play a role in "diverging" cancer patients away from the emergency room, and t…

1
Ep 85. ALK-Positive Lung Cancer: The 2024 Update 34:39

3M ago34:39

34:39

In this episode, Dr. Paul Wheatley-Price sits down with Dr. Geoffrey Liu, Medical Oncologist at Princess Margaret Cancer Center and a Canadian leader in opening dozens of clinical trials. Dr. Liu gives a rundown of everything you need to know about ALK-positive lung cancer - what is ALK, how common is it, how this type of lung cancer is treated, an…

1
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations 58:19

3M ago58:19

58:19

Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations.Av Neil Love, MD

1
Caregiving for Your Loved One with Cancer 51:52

3M ago51:52

51:52

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Caregiving for a Friend- Caregivers for Cancer Survivors- Couples, Partners, Siblings & Friends- Family, Partner & Friend Communication- Care Coordination: Challenges & Tips- Stresses on Family, Partners &…

1
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors 59:19

3M ago59:19

59:19

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.Av Neil Love, MD

1
Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation 2:03:22

4M ago2:03:22

2:03:22

Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates …

1
Current Perspectives on Cancer Survivorship 55:47

4M ago55:47

55:47

- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…

1
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC

4M ago

—

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…

1
Poster Pearl: Dato-DXd Demonstrates Intracranial Efficacy in NSCLC

4M ago

—

Host: Jacob Sands, MD Guest: Aaron Lisberg, MD Brain metastases are a frequent complication of lung cancer, which is why the TROPION-Lung05 trial evaluated the intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced metastatic non-small cell lung cancer (NSCLC). According to the data, Dato-DXd demonst…

1
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer 1:01:23

4M ago1:01:23

1:01:23

Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.Av Neil Love, MD

1
Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer 1:01:43

5M ago1:01:43

1:01:43

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment…

1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer 1:00:53

5M ago1:00:53

1:00:53

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.Av Neil Love, MD

1
Ep 81. Best Of ASCO 2024 37:21

5M ago37:21

37:21

In this episode, Dr. Paul Wheatley-Price and Dr. Rosalyn Juergens, Medical Oncologist at the Juravinski Cancer Center and Co-Chair of LCC's Medical Advisory Committee, discuss the top highlights in lung cancer research presented at the 2024 ASCO Annual Conference held in Chicago this past June.Av Lung Cancer Canada

1
Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation 47:34

5M ago47:34

47:34

Dr Jonathan W Goldman from UCLA Health in Santa Monica, California summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation.Av Neil Love, MD

1
Ep 79. Joys & Challenges Of Lung Cancer Care In Rural Communities 40:53

6M ago40:53

40:53

In this episode, Dr. Paul Wheatley-Price chats with Dr. Michela Febbraro and Dr. Silvana Spadafora, Medical Oncologists at the Algoma District Cancer Centre in Sault Ste. Marie, ON and also, mother-and daughter-duo. They talk about the joys, challenges, and everything in between of living and caring for patients with lung cancer in rural and remote…

1
Current Perspectives on the Future of Cancer Research 1:13:03

6M ago1:13:03

1:13:03

- Understanding the Future of Cancer Research & Clinical Trials- Increased Focus on Earlier Detection & Treatment of Cancer- Health Care Disparities Research- Enhanced Knowledge of the Molecular Portrait of Cancer- Artificial Intelligence (AI) Driven Approaches for Diagnosis & Treatment of Cancer- Microsatellite Instability (MSI): Mutations in DNA …

1
Non-Small Cell Lung Cancer: For Caregivers 53:17

6M ago53:17

53:17

- Overview of Non-Small Cell Lung Cancer- The Important Role of the Caregiver in Communicating with the Health Care Team- Taking on the Role of the Caregiver- What Research Tells Us About Caregivers- The Caregiver’s Role in Decision Making for a Loved One with Non-Small Cell Lung Cancer- Challenges in Communicating with the Health Care Team- Challe…

1
How Health Care Disparities May Influence Your Cancer Treatment 59:22

6M ago59:22

59:22

- Disproportionate Burden of COVID & Cancer on People of Color- Social Determinants of Health, Including Languages Spoken & Health Literacy- Influence of the Local & Regional Environment in Which You Live on Your Access to Oncology Care- Effect of COVID on Health Care Systems- How Race May Impact Your Access to Cancer Treatment, Management of Treat…

1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer 1:00:48

7M ago1:00:48

1:00:48

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets.Av Neil Love, MD

1
What’s New in Precision Medicine 1:00:04

7M ago1:00:04

1:00:04

- Understanding Precision Medicine: Overview & Value of Precision Medicine- How Precision Medicine is Different from Targeted Treatments?- Precision Medicine Role’s in Informing Treatment Decisions: Predicting Response to Treatment- The Role of Precision Medicine in Deciding the Treatment for Lung Cancer, Leukemia & Colon Cancer- Talking with Your …

1
Ep 78. Research in Canada: Dr. Alain Tremblay GOMRG Winner 22:51

7M ago22:51

22:51

In today's episode, Dr. Paul Wheatley-Price sits down with Dr. Alain Tremblay, Professor of Medicine and Respirologist at the University of Calgary and Medical Lead of the Alberta Lung Cancer Screening program. Dr. Tremblay is the winner of the 2023 Geoffrey Ogram Memorial Research Grant for his project on implementing artificial intelligence (AI) …

1
Ep 77. Spotlight on Lung Cancer in Alberta 20:56

7M ago20:56

20:56

In this episode, Dr. Paul Wheatley-Price sits down with Nina Snyder, Chief Operations Officer at Alberta Lung. Nina introduces Alberta Lung as an organization and what they do to support Albertans living with lung disease, factors like radon and air quality that may lead to a lung cancer diagnosis, challenges like isolation, youth vaping and e-ciga…

1
Caring for Your Loved One with Cancer 1:00:43

8M ago1:00:43

1:00:43

- Definition of a Caregiver- What Research Tells Us About Caregivers’ Well Being- Caregiving for an Older Adult- Caregiving for a Younger Adult- Couples, Partners, Siblings, & Friends- Challenges for Caregivers of Cancer Survivors- Family, Partner, & Friend Communication- Care Coordination Challenges & Tips- Stresses on Family, Partners, Friends, &…

1
Diverse Populations Participating in Decisions about Your Care 57:57

8M ago57:57

57:57

- How Being a Member of Diverse Communities May Impact Your Access to Oncology Care, Treatment, Management of Treatment Side Effects & Pain Management- What to Expect from Your Relationship with Your Health Care Team: Is Your Health Care Team Providing You with Equitable, Excellent Care- What to Consider When Selecting a Cancer Care Team & Treatmen…

Podcaster värda att lyssna på

Lung Cancer podcaster

Podcaster värda att lyssna på

Snabbguide